Journal of Reports in Pharmaceutical Sciences
Evaluation of Cytotoxic and Apoptotic Effects of DT386–BR2: A Promising Anticancer Fusion Protein
Author(s):
1Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
Published online:Jun 26, 2020
Article type:Research Article
Received:Feb 04, 2019
Accepted:Oct 01, 2019
How to Cite:Shafiee F, Rabbani Khorasgani M, Jahanian-Najafabadi A. Evaluation of Cytotoxic and Apoptotic Effects of DT386–BR2: A Promising Anticancer Fusion Protein. J Rep Pharm Sci. 2020;9(1):e147284. doi: https://doi.org/10.4103/jrptps.JRPTPS_15_19
Abstract
Copyright
© 2020, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Crossmark
Checking
Comments
Number of Comments:0Cited by
- Scopus by DOI: 7
Last Update: 2 weeks ago
- Scopus by Title: 7
Last Update: 2 weeks ago
- Scopus by Title (Ref): 0
Last Update: 2 weeks ago
- CrossRef: 4
Last Update: 6 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles